EP1085897A4 - ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT) - Google Patents

ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT)

Info

Publication number
EP1085897A4
EP1085897A4 EP99923129A EP99923129A EP1085897A4 EP 1085897 A4 EP1085897 A4 EP 1085897A4 EP 99923129 A EP99923129 A EP 99923129A EP 99923129 A EP99923129 A EP 99923129A EP 1085897 A4 EP1085897 A4 EP 1085897A4
Authority
EP
European Patent Office
Prior art keywords
acrp30r1l
acrp30
homolog
related protein
adipocyte complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99923129A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1085897A1 (en
Inventor
Preston Hensley
Xiaotong Li
Erding Hu
Randall Forrest Smith
Yuan Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1085897A1 publication Critical patent/EP1085897A1/en
Publication of EP1085897A4 publication Critical patent/EP1085897A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP99923129A 1998-05-21 1999-05-18 ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT) Withdrawn EP1085897A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US162352 1980-06-23
US175501 1988-04-13
US8656298P 1998-05-21 1998-05-21
US86562P 1998-05-21
US16235298A 1998-09-29 1998-09-29
US17550198A 1998-10-20 1998-10-20
PCT/US1999/010822 WO1999059618A1 (en) 1998-05-21 1999-05-18 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)

Publications (2)

Publication Number Publication Date
EP1085897A1 EP1085897A1 (en) 2001-03-28
EP1085897A4 true EP1085897A4 (en) 2003-03-12

Family

ID=27375431

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99923129A Withdrawn EP1085897A4 (en) 1998-05-21 1999-05-18 ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT)

Country Status (3)

Country Link
EP (1) EP1085897A4 (ja)
JP (1) JP2003527067A (ja)
WO (1) WO1999059618A1 (ja)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010102130A (ko) 1999-02-19 2001-11-15 리스 데브라 케이. 지혈 및 면역기능에 사용하기 위한 억제제
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
JP2002541846A (ja) * 1999-04-20 2002-12-10 ザイモジェネティクス，インコーポレイティド 脂肪細胞補体関連タンパク質同族体ｚａｃｒｐ２
US6620909B1 (en) 1999-04-20 2003-09-16 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp2
EP1173483A4 (en) * 1999-04-28 2002-07-10 Smithkline Beecham Corp ACRP30R1M, APPROVED BY ACRP30
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001297656A1 (en) * 2000-11-29 2002-09-19 Zymogenetics, Inc. Adipocyte complement related protein zacrp11
AU2002226033A1 (en) 2000-12-07 2002-06-18 Zymogenetics Inc. Adipocyte complement related protein zacrp3x2
WO2003009862A1 (en) * 2001-07-20 2003-02-06 Genset S.A. Agonists and antagonists of modumet for use in the treatment of metabolic disorders
WO2003009864A1 (en) * 2001-07-23 2003-02-06 Genset S.A. Agonists and antagonists of disomet for the treatment of metabolic disorders
WO2003009861A1 (en) * 2001-07-24 2003-02-06 Genset S.A. Agonists and antagonists of metabolix in the treatment of metabolic disorders
WO2003009865A1 (en) * 2001-07-25 2003-02-06 Genset S.A. Agonists and antagonists of energen for use in the treatment of metabolic disorders
WO2003009863A1 (en) * 2001-07-26 2003-02-06 Genset S.A. Agonists and antagonists of cofoxin for use in the treatment of metabolic disorders
WO2003011325A1 (en) * 2001-07-27 2003-02-13 Genset S.A. Agonists and antagonists of moceptin for the treatment of metabolic disorders
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
WO2003011321A1 (en) * 2001-07-31 2003-02-13 Genset S.A. Agonists and antagonists of cobesin for the treatment of metabolic disorders
US20050054565A1 (en) * 2001-07-31 2005-03-10 John Lucas Agonists and antagonists of moxifin for the treatment of metabolic disorders
US20070129291A1 (en) * 2001-08-01 2007-06-07 Genset S.A. Genobix agonists and antagonists for use in the treatment of metabolic disorders
WO2003011318A1 (en) * 2001-08-01 2003-02-13 Genset S.A. Agonists and antagonists of famoset for use in the treatment of metabolic disorders
EP1418934A1 (en) 2001-08-02 2004-05-19 Genset S.A. Xobesin agonists and antagonists for the treatment of metabolic disorders
WO2003011320A1 (en) * 2001-08-02 2003-02-13 Genset S.A. Agonists and antagonists of obesingen for the treatment of metabolic disorders
WO2003011322A1 (en) * 2001-08-02 2003-02-13 Genset S.A. Agonists and antagonists of genoxin for use in the treatment of metabolic disorders
WO2003013580A1 (en) * 2001-08-03 2003-02-20 Genset S.A. Tr xidatin agonists and antagonists treatment of metabolic disorders
WO2003013579A1 (en) * 2001-08-03 2003-02-20 Genset S.A. Lypergix agonists and antagonists for use in the treatment of metabolic disorders
WO2003013581A1 (en) * 2001-08-03 2003-02-20 Genset S.A. Agonists and antagonists of genceptin for the treatment of metabolic disorders
WO2003013582A1 (en) * 2001-08-06 2003-02-20 Genset S.A. Genoxit agonists and antagonists for use in the treatment of metabolic disorders
WO2003013578A1 (en) * 2001-08-07 2003-02-20 Genset S.A. Omoxin agonists and antagonists for use in the treatment of metabolic disorders
WO2003013585A1 (en) * 2001-08-08 2003-02-20 Genset S.A. Mifaxin agonists and antagonists for use in the treatment of metabolic
WO2003013584A1 (en) * 2001-08-09 2003-02-20 Genset S.A. Xafinix agonists and antagonists for use in the treatment of metabolic disorders
WO2003013604A2 (en) * 2001-08-09 2003-02-20 Genset S.A. Migenix agonists and antagonists for use in the treatment of metabolic disorders
WO2003013583A1 (en) * 2001-08-10 2003-02-20 Genset S.A. Faxigen agonists and antagonists in the treatment of metabolic disorders
WO2003026695A1 (en) * 2001-09-21 2003-04-03 Genset S.A. Agonists and antagonists of cylixin for the treatment of metabolic disorders
WO2003041730A1 (en) * 2001-11-16 2003-05-22 Genset S.A. Ditacin agonists and antagonists for use in the treatment of metabolic disorders
US20060089311A1 (en) * 2001-11-28 2006-04-27 Deno Dialvnas Agonists and antagonists of ryzn for the treatment of metabolic disorders
US7344843B2 (en) 2001-11-29 2008-03-18 Serono Genetics Institute S.A. Agonists and antagonists of prolixin for the treatment of metabolic disorders
AU2002339683A1 (en) * 2001-12-05 2003-06-17 Genset S.A. Agonist and antagonists of redax for the treatment of metabolic disorders
WO2003047615A1 (en) * 2001-12-05 2003-06-12 Genset S.A. Dexar agonists and antagonists for use in the treatment of metabolic disorders
AU2002339681A1 (en) * 2001-12-12 2003-06-23 Genset S.A. Agonists and antagonists of glucomin for the treatment of metabolic disorders
AU2002339682A1 (en) * 2001-12-13 2003-06-23 Genset S.A. Emergen agonists and antagonists for use in the treatment of metabolic disorders
AU2002339685A1 (en) * 2001-12-13 2003-06-23 Genset S.A. Agonists and antagonists of oxifan for the treatment of metabolic disorders
WO2003049756A1 (en) * 2001-12-13 2003-06-19 Genset S.A. Glucomin agonists and antagonists for use in the treatment of metabolic disorders
AU2002339688A1 (en) * 2001-12-14 2003-06-30 Genset S.A. Glucoset agonists and antagonists for use in the treatment of metabolic disorders
WO2003055509A1 (en) * 2001-12-26 2003-07-10 Genset S.A. Agonists and antagonists of bromix for the treatment of metabolic disorders
AU2003219167A1 (en) * 2002-03-19 2003-09-29 Genset Sa Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists
EP1685846B1 (en) * 2003-11-04 2014-11-26 Daiichi Sankyo Company, Limited Antitumor agent

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] "3o KD Adipocyte complement-related protein precursor", XP002214473, Database accession no. AA732948 *
MAEDA K ET AL: "CNDA CLONING AND EXPRESSION OF A NOVEL ADIPOSE SPECIFIC COLLAGEN- LIKE FACTOR, APM1 (ADIPOSE MOST ABUNDANT GENE TRANSCRIPT)", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 221, 1 April 1996 (1996-04-01), pages 286 - 289, XP000612064, ISSN: 0006-291X *
SCHERER P E ET AL: "A NOVEL SERUM PROTEIN SIMILAR TO C1Q, PRODUCED EXCLUSIVELY IN ADIPOCYTES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 270, no. 45, 1 November 1995 (1995-11-01), pages 26746 - 26749, XP000612012, ISSN: 0021-9258 *
See also references of WO9959618A1 *

Also Published As

Publication number Publication date
EP1085897A1 (en) 2001-03-28
JP2003527067A (ja) 2003-09-16
WO1999059618A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
EP1085897A4 (en) ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT)
TW418677U (en) Disposable garments
HK1026616A1 (en) Anti-proliferative preparations
PT1775346E (pt) Análogos de hormonas glicoproteicas reticulados com ligações dissulfureto, sua preparação e utilização
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
HUP0003762A3 (en) Adipocyte-specific protein homologs
GB9811762D0 (en) S'-Deoxy-cytidine derivatives
EP1080182A4 (en) AMINO ACID MODIFIED POLYPEPTIDES
PL339085A1 (en) Recombinative expression of insulin peptide c
EP1083923A4 (en) ACRP30R1: HOMOLOGY OF ACRP30 (30 KDA ADIPOCYTE COMPLEMENT-RELATED PROTEIN)
IL123098A0 (en) Placental protein 13
IL145971A0 (en) Adipocyte complement related protein homolog zacrp3
HU9801775D0 (en) Bereznai's bnsc-wc system
AU133723S (en) Men's shaver
IL146011A0 (en) Adipocyte complement related protein homolog zacrp2
GB9724307D0 (en) Improvements relating to protein accumulation
GB0107378D0 (en) Sequence encoding CYSDV coat protein
EP1012155A4 (en) HUMAN ORIGIN DECOUPLING PROTEIN 3
PL344349A1 (en) Human protein c polypeptide
AU6690498A (en) Human tubby homolog
HUP0002905A3 (en) 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
EP1173483A4 (en) ACRP30R1M, APPROVED BY ACRP30
GB9715719D0 (en) Titanium proteins
GB2323010B (en) Windrower
HU9502341D0 (en) "nyarad 7,4"type smoothing stick

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20030128

17Q First examination report despatched

Effective date: 20040701

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050112